Randomized Trialhigh evidence

Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial.

Atherosclerosis·August 1, 2026·PMID 42435732

Why it matters

For cardiologists managing chronic CAD, this trial provides randomized evidence that a comprehensive, PET-guided strategy—reserving revascularization for severely reduced CFC—improves hard outcomes over standard care. It reinforces the value of integrating advanced imaging to safely defer revascularization while intensifying prevention.

Infographic summary of Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled